These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21679017)

  • 1. Febrile reactions after transrectal ultrasound-guided prostatic biopsy: a retrospective study.
    Hedelin H; Claesson BE; Wilpart A
    Scand J Urol Nephrol; 2011 Dec; 45(6):393-6. PubMed ID: 21679017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Young JL; Liss MA; Szabo RJ
    Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
    Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
    J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?
    Carignan A; Roussy JF; Lapointe V; Valiquette L; Sabbagh R; Pépin J
    Eur Urol; 2012 Sep; 62(3):453-9. PubMed ID: 22575912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
    Hernandez-Graulau JM
    Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis.
    Adibi M; Hornberger B; Bhat D; Raj G; Roehrborn CG; Lotan Y
    J Urol; 2013 Feb; 189(2):535-40. PubMed ID: 22982426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
    Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin.
    Lee JK; Lee S; Hong SK; Byun SS; Lee SE
    BMC Urol; 2016 Aug; 16(1):51. PubMed ID: 27557527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infections after transrectal ultrasonic guided prostate biopsies - a retrospective study.
    Danielsen L; Faizi G; Snitgaard S; Lund L; Frey A
    Scand J Urol; 2019; 53(2-3):97-101. PubMed ID: 31070079
    [No Abstract]   [Full Text] [Related]  

  • 20. A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.
    Samarinas M; Dimitropoulos K; Zachos I; Gravas S; Karatzas A; Tzortzis V
    World J Urol; 2016 Nov; 34(11):1555-1559. PubMed ID: 26951136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.